Plasma Diaphanous Related Formin 1 Levels Are Associated with Altered Glucose Metabolism and Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Case Control Study
Table 2
The correlations between clinical indicators and DIAPH1.
Total
OW
PCOS
value
value
value
Age (y)
0.021
0.798
0.206
0.057
0.119
0.308
BMI (kg/m2)
0.104
0.202
-0.077
0.481
-0.083
0.479
WHR
0.162
0.047
0.119
0.275
0.075
0.524
FBG (mmol/L)
0.351
<0.0001
0.379
< 0.001
0.464
<0.0001
FINS (mU/mL)
-0.021
0.799
-0.207
0.056
-0.112
0.337
HbA1c (%)
0.034
0.679
0.023
0.834
0.281
0.015
HOMAIR
0.067
0.412
-0.090
0.412
0.040
0.733
HOMA-β
-0.211
0.009
-0.371
< 0.001
-0.327
0.004
TG (mmol/L)
0.101
0.217
0.017
0.874
0.155
0.185
TC (mmol/L)
0.178
0.029
0.228
0.035
0.184
0.115
HDL-C (mmol/L)
0.034
0.680
0.123
0.258
-0.036
0.761
LDL-C (mmol/L)
0.033
0.685
0.030
0.787
0.109
0.352
ALT (IU/L)
0.071
0.386
-0.048
0.664
0.082
0.484
AST (IU/L)
0.070
0.389
0.027
0.805
0.080
0.494
γ-GGT (IU/L)
0.124
0.128
-0.007
0.948
0.312
0.006
UA (μmol/L)
-0.033
0.687
-0.277
0.010
-0.038
0.743
Creatinine (μmol/L)
-0.099
0.224
-0.152
0.162
0.033
0.779
BUN (mmol/L)
-0.095
0.245
0.029
0.788
-0.026
0.823
Testosterone (nmol/L)
-0.053
0.526
-0.234
0.030
-0.054
0.643
LH (mIU/L)
-0.106
0.210
-0.109
0.318
-0.066
0.572
FSH (mIU/L)
0.132
0.117
0.145
0.182
0.155
0.185
LH/FSH
-0.172
0.040
-0.243
0.024
-0.082
0.483
Estradiol (pg/mL)
0.117
0.163
0.345
0.001
0.033
0.781
Progesterone (ng/mL)
0.125
0.137
0.268
0.013
0.022
0.850
PRL (ng/mL)
-0.013
0.873
-0.028
0.799
-0.020
0.867
WBC (10^9/L)
-0.048
0.557
-0.129
0.239
0.038
0.746
The correlations were determined by the Spearman analysis. Total: all participants; OW: overweight participants; PCOS: participants with polycystic ovary syndrome.
